昂利康：子公司非那雄胺原料药获得化学原料药上市申请批准通知书

Core Viewpoint - The company Anglikang (002940) announced that its subsidiary, Hunan Keri Biopharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the raw material drug Finasteride [1] Group 1 - Finasteride is classified as a type II 5-alpha reductase inhibitor [1] - The formulation of Finasteride is primarily used in clinical settings for the treatment of benign prostatic hyperplasia (BPH) and male androgenetic alopecia [1]